share_log

Cardio Diagnostics | EFFECT: Others

Cardio Diagnostics | EFFECT:其他

美股sec公告 ·  02/02 06:10
Moomoo AI 已提取核心信息
Cardio Diagnostics Holdings, Inc. has achieved a significant milestone with the United States Securities and Exchange Commission (SEC) declaring its Form S-3 effective as of February 1, 2024, at 11:00 A.M. This form is a registration statement that allows companies to issue various securities to the public. The effectiveness of this form indicates that Cardio Diagnostics Holdings has met all the necessary regulatory requirements to proceed with the issuance of securities.
Cardio Diagnostics Holdings, Inc. has achieved a significant milestone with the United States Securities and Exchange Commission (SEC) declaring its Form S-3 effective as of February 1, 2024, at 11:00 A.M. This form is a registration statement that allows companies to issue various securities to the public. The effectiveness of this form indicates that Cardio Diagnostics Holdings has met all the necessary regulatory requirements to proceed with the issuance of securities.
Cardio Diagnostics Holdings, Inc.取得了重要的里程碑,美国证券交易委员会(SEC)宣布其S-3表格自2024年2月1日上午11点起生效。该表格是一份注册声明,允许公司向公众发行各种证券。该表格的有效性表明,Cardio Diagnostics Holdings已满足所有必要的监管要求,可以继续发行证券。
Cardio Diagnostics Holdings, Inc.取得了重要的里程碑,美国证券交易委员会(SEC)宣布其S-3表格自2024年2月1日上午11点起生效。该表格是一份注册声明,允许公司向公众发行各种证券。该表格的有效性表明,Cardio Diagnostics Holdings已满足所有必要的监管要求,可以继续发行证券。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息